Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

FLORHAM PARK, N.J., Jan. 04, 2024 -- Celularity Inc. a biotechnology company developing allogeneic cell therapies and advanced biomaterial products, today confirmed that it has entered into an...

Related Keywords

United States ,Robertj Hariri ,Carlos Ramirez ,Biocellgraft Inc ,Globenewswire Inc ,Securities Exchange ,Exchange Commission ,Celularity Inc ,Nasdaq ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Investor Contacts ,